Target reported dismal earnings, but new CEO Michael Fiddelke unveiled a $6B turnaround plan for 2026. However, analysts are skeptical leadership can turn the page.

Data access empowerment operating models enable public health leaders to make timely, informed decisions with trusted intelligence and faster insights.

Amphenol maintains a Buy rating with a revised target price of $155, implying 17.7% upside driven by robust Q4 and full-year 2025 results. Click here to read more macro analysis here.

In this article, we will take a look at the Dividend Kings List: Top 15 Stocks. Dividend Kings are a small group of companies that have raised their dividends for at least 50 consecutive years. Stocks ...

Acorn Energy, Inc. (NASDAQ:ACFN) Q4 2025 Earnings Call Transcript March 5, 2026 Operator: Good morning, everyone, and welcome to Acorn Energy’s Fourth Quarter and Full Year 2025 Conference Call.

Quality evidence is needed to support a new Medicare Part D medication therapy management (MTM) program performance measure, prompting a scoping review on MTM services and associated outcomes.

Decisions often drift because there's no forcing function, not because people are indecisive. Without a cadence that demands ...

Researchers at the National University of Singapore (NUS) have identified a protein called tyrosine phosphatase 1B (PTP1B) as ...

T he display of American and Israeli firepower in Iran has been more fast-paced and overwhelming than America showed off in either of the first two Persian Gulf wars. The two alli ...

Depending on their experience with value-based payment models, providers may need to invest in new or enhanced operational capacities.